Group One Trading, L.P. Heron Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.32 - $3.86 $125,864 - $209,412	54,252 New	54,252 $189,000
Q2 2023 Aug 09, 2023	SELL	$1.11 - $2.88 $1,416 - $3,674	-1,276 Reduced 13.82%	7,959 $9,000
Q1 2023 May 12, 2023	BUY	$1.51 - $3.25 $7,305 - $15,723	4,838 Added 110.03%	9,235 $13,000
Q4 2022 Feb 09, 2023	BUY	$2.25 - $4.67 $5,031 - $10,442	2,236 Added 103.47%	4,397 $10,000
Q3 2022 Nov 09, 2022	SELL	$2.66 - $5.37 $23,796 - $48,040	-8,946 Reduced 80.54%	2,161 $9,000
Q2 2022 Aug 11, 2022	SELL	$2.3 - $6.29 $19,147 - $52,364	-8,325 Reduced 42.84%	11,107 $31,000
Q1 2022 May 12, 2022	BUY	$4.63 - $9.94 $46,554 - $99,946	10,055 Added 107.23%	19,432 $111,000
Q4 2021 Feb 11, 2022	BUY	$8.35 - $12.6 $78,297 - $118,150	9,377 New	9,377 $86,000
Q3 2021 Nov 12, 2021	SELL	$10.13 - $15.0 $78,213 - $115,815	-7,721 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$13.27 - $18.48 $102,457 - $142,684	7,721 New	7,721 $120,000
Q4 2020 Feb 10, 2021	SELL	$14.61 - $22.14 $111,036 - $168,264	-7,600 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$13.67 - $17.77 $112,681 - $146,478	-8,243 Reduced 52.03%	7,600 $113,000
Q2 2020 Aug 13, 2020	BUY	$10.89 - $21.47 $135,820 - $267,773	12,472 Added 369.98%	15,843 $233,000
Q1 2020 May 13, 2020	SELL	$10.23 - $24.56 $80,898 - $194,220	-7,908 Reduced 70.11%	3,371 $40,000
Q4 2019 Feb 10, 2020	SELL	$17.42 - $26.61 $34,038 - $51,995	-1,954 Reduced 14.77%	11,279 $265,000
Q3 2019 Nov 12, 2019	BUY	$16.36 - $21.39 $216,491 - $283,053	13,233 New	13,233 $245,000
Q2 2019 Aug 09, 2019	SELL	$16.93 - $26.22 $54,514 - $84,428	-3,220 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$23.15 - $28.34 $8,357 - $10,230	-361 Reduced 10.08%	3,220 $79,000
Q4 2018 Feb 06, 2019	SELL	$22.03 - $32.01 $98,672 - $143,372	-4,479 Reduced 55.57%	3,581 $93,000
Q3 2018 Nov 08, 2018	BUY	$30.0 - $40.85 $38,880 - $52,941	1,296 Added 19.16%	8,060 $255,000
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $562,320 - $894,600	-21,300 Reduced 75.9%	6,764 $263,000
Q1 2018 May 11, 2018	SELL	$18.43 - $28.8 $556,770 - $870,048	-30,210 Reduced 51.84%	28,064 $775,000
Q4 2017 Feb 09, 2018	BUY	$14.8 - $18.85 $491,626 - $626,159	33,218 Added 132.58%	58,274 $1.06 Million
Q3 2017 Nov 15, 2017	SELL	$14.65 - $16.85 $89,408 - $102,835	-6,103 Reduced 19.59%	25,056 $405,000
Q2 2017 Aug 14, 2017	BUY	N/A	31,159	31,159 $432,000

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$28.6 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$9.47 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$9.33 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$8.91 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$7.48 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account